Polymer-Based Sustained-Release Dosage Forms for Protein Drugs, Challenges, and Recent Advances
Authors:
- 16 December 2008
- journal article
- review article
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 9 (4) , 1218-1229
Abstract
While the concept of using polymer-based sustained-release delivery systems to maintain therapeutic concentration of protein drugs for extended periods of time has been well accepted for decades, there has not been a single product in this category successfully commercialized to date despite clinical and market demands. To achieve successful systems, technical difficulties ranging from protein denaturing during formulation process and the course of prolonged in vivo release, burst release, and incomplete release, to low encapsulation efficiency and formulation complexity have to be simultaneously resolved. Based on this updated understanding, formulation strategies attempting to address these aspects comprehensively were reported in recent years. This review article (with 134 citations) aims to summarize recent studies addressing the issues above, especially those targeting practical industrial solutions. Formulation strategies representative of three areas, microsphere technology using degradable hydrophobic polymers, microspheres made of water soluble polymers, and hydrophilic in vivo gelling systems will be selected and introduced. To better understand the observations and conclusions from different studies for different systems and proteins, physicochemical basis of the technical challenges and the pros and cons of the corresponding formulation methods will be discussed.Keywords
This publication has 120 references indexed in Scilit:
- Biodegradable micro-osmotic pump for long-term and controlled release of basic fibroblast growth factorJournal of Controlled Release, 2007
- Recombinant gelatin hydrogels for the sustained release of proteinsJournal of Controlled Release, 2007
- Conjugates of poly(DL‐lactide‐co‐glycolide) on amino cyclodextrins and their nanoparticles as protein delivery systemJournal of Biomedical Materials Research Part A, 2006
- Efficacy and immunogenicity of novel erythropoietic agents and conventional rhEPO in rats with renal insufficiencyKidney International, 2006
- Erythropoietin‐induced, antibody‐mediated pure red cell aplasia*European Journal of Clinical Investigation, 2005
- Controlled release from fibers of polyelectrolyte complexesJournal of Controlled Release, 2005
- A new sustained‐release preparation of human growth hormone and its pharmacokinetic, pharmacodynamic and safety profileClinical Endocrinology, 2005
- Development of Biodegradable Injectable Thermoplastic OligomersBiomacromolecules, 2004
- Phase Separation of Aqueous Mixtures of Poly(ethylene oxide) and DextranMacromolecules, 2003
- Novel injectable neutral solutions of chitosan form biodegradable gels in situBiomaterials, 2000